E-LIB Suche - Ergebnisse für: Lee, Won Sik

1

Pembrolizumab for Patients with Relapsed or Refractory Extr..:

Lee, Ji Yun ; Kwon, Ji Hyun ; Hur, Joon Young...
Cancer Research and Treatment. 56 (2024) 2 - p. 681-687 , 2024

Link: https://doi.org/10.4143/..

2

Long-term efficacy and safety of tucidinostat in patients w..:

Rai, Shinya ; Kim, Won Seog ; Ando, Kiyoshi...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

3

Superior outcomes and high-risk features with carfilzomib, ..:

Lee, Ji Hyun ; Choi, Jimin ; Min, Chang-Ki...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

4

Evaluation of the R2‐ISS in real‐world patients with newly ..:

Cho, Hyungwoo ; Kim, Kihyun ; Yoon, Sang Eun...
HemaSphere. 8 (2024) 1 - p. , 2024

Link: https://doi.org/10.1002/..

5

Geriatric risk model for older patients with diffuse large ..:

Yhim, Ho-Young ; Park, Yong ; Kim, Jeong-A...
The Korean Journal of Internal Medicine. 39 (2024) 3 - p. 501-512 , 2024

Link: https://doi.org/10.3904/..

6

Early dose reduction of dasatinib does not compromise clini..:

Shin, Dong-Yeop ; Park, Sahee ; Jang, Eunjung...
Leukemia Research. 143 (2024) - p. 107542 , 2024

Link: https://doi.org/10.1016/..

7

Predictive role of absolute lymphocyte count in daratumumab..:

Cho, Hee Jeong ; Jo, Jae-Cheol ; Lee, Yoo Jin...
The Korean Journal of Internal Medicine. 38 (2023) 2 - p. 238-247 , 2023

Link: https://doi.org/10.3904/..

8

Venadaparib Is a Novel and Selective PARP Inhibitor with Im..:

Lee, Myongjae ; Je, In-Gyu ; Kim, Jeong Eun...
Molecular Cancer Therapeutics. 22 (2023) 3 - p. 333-342 , 2023

Link: https://doi.org/10.1158/..

9

Incidence and risk factors of opportunistic infections afte..:

Kim, Da Jung ; Jeong, Seri ; Kong, Seom Gim...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

A non-interventional, post-marketing surveillance study eva..:

Jo, Jae-Cheol ; Jeon, Youngwoo ; Kim, DaJung...
Expert Opinion on Biological Therapy. 23 (2023) 8 - p. 737-747 , 2023

Link: https://doi.org/10.1080/..

11

P-135 Evaluation of the R2-ISS in real-world patients with ..:

Cho, Hyungwoo ; Kim, Kihyun ; Yoon, Sang Eun...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S109-S110 , 2023

Link: https://doi.org/10.1016/..

12

Comparison of first-line treatment with CHOP versus ICED in..:

Kim, Seok Jin ; Jo, Jae-Cheol ; Yoon, Dok Hyun...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

13

Effects of food and ethnicity on the pharmacokinetics of ve..:

Kim, Hyun Chul ; Yang, Eunsol ; Lee, Soyoung...
Investigational New Drugs. 42 (2023) 1 - p. 80-88 , 2023

Link: https://doi.org/10.1007/..

14

P-284 Carfilzomib, lenalidomide, and dexamethasone combinat..:

Lee, Ji Hyun ; Min, Chang-Ki ; Jo, Jae-Cheol...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S192-S193 , 2023

Link: https://doi.org/10.1016/..

15

Current Treatment Patterns and the Role of Upfront Autologo..:

Cho, Hyungwoo ; Yoon, Dok Hyun ; Shin, Dong-Yeop...
Cancer Research and Treatment. 55 (2023) 2 - p. 684-692 , 2023

Link: https://doi.org/10.4143/..